Pricing Log in Create free account

DBV Technologies S.A. (DBVT) vs Immix Biopharma, Inc. (IMMX)

DBV Technologies S.A. and Immix Biopharma, Inc. are both Biotechnology companies. DBV Technologies S.A. and Immix Biopharma, Inc. are of similar size ($723.3M and $692.2M). Immix Biopharma, Inc. has the higher net margin (0.00% vs −5,547.3%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Immix Biopharma, Inc. leads on 10 and DBV Technologies S.A. on 2.

Valuation

Metric DBVT IMMX Biotechnology median
P/E n/m n/m 10.96
P/S 279.11 n/m 9.52
P/B 7.02 2.34 2.23
Price to free cash flow n/m n/m 25.69
EV/EBITDA n/m n/m 0.68
EV/Sales 234.82 n/m 9.00
Earnings yield (26.72%) (10.49%) (32.09%)
Free cash flow yield (18.39%) (7.31%) (22.62%)

Profitability

Metric DBVT IMMX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin (5,571.63%) 0.00% 0.00%
Net margin (5,547.30%) 0.00% 0.00%
Free cash flow margin (5,131.50%) 0.00% 0.00%
Return on equity (205.75%) (34.18%) (50.12%)
Return on assets (127.19%) (31.34%) (45.12%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DBVT IMMX Biotechnology median
Revenue growth (TTM) (33.42%) — 6.78%
EPS growth (last fiscal year) 10.26% (17.11%) 29.88%
Revenue growth, 5-year CAGR (12.95%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DBVT IMMX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.24 25.13 4.74
Net debt to EBITDA 1.35 3.39 1.01

Dividend

Metric DBVT IMMX Biotechnology median
Dividend yield — — 0.40%
Payout ratio — — —

Size

Metric DBVT IMMX Biotechnology median
Market cap 723.29m 692.24m 166.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack